Blog
RSS FeedPosted by Michael Wonder on 23 May 2024
Historical archive of the Schedule of Pharmaceutical Benefits (1951-2002)
23 May 2024 - The Department of Health and Aged Care has completed the digitisation, and is making available for public ...
Posted by Michael Wonder on 22 May 2024
$43.9 million to boost fight against HIV infection
21 May 2024 - The Albanese Government is investing $43.9 million to put Australia on track to eliminate transmission of ...
Posted by Michael Wonder on 17 May 2024
Chemists to lose dollar discount option as government bows to Pharmacy Guild pressure
16 May 2024 - Chemist Warehouse will be stripped of its ability to give its customers $1 off their medicines, ...
Posted by Michael Wonder on 16 May 2024
It is time to reconsider the 3% discount rate
15 May 2024 - Health technology assessment guidance often recommends a 3% real annual discount rate, the appropriateness of which ...
Posted by Michael Wonder on 14 May 2024
Budget 2024–25: cheaper medicines, new Medicare Urgent Care Clinics and more free mental health services in a stronger Medicare
14 May 2024 - The Albanese Labor Government is continuing to improve our health system: strengthening Medicare, the heart of universal ...
Posted by Michael Wonder on 13 May 2024
A systematic review on the appropriate discounting rates for the economic evaluation of gene therapies: whether a specific approach is justified to tackle the challenges
10 May 2024 - Discounting the cost and effect for health intervention is a controversial topic over the last two decades. ...
Posted by Michael Wonder on 13 May 2024
Australians benefit from new life changing medicines added to the PBS
13 May 2024 - Women with endometrial cancer and people with itching associated with chronic kidney disease will benefit from ...
Posted by Michael Wonder on 10 May 2024
Agenda for the July 2024 PBAC meeting (version 3)
10 May 2024 - The Department of Health has published a revised agenda for the July 2024 PBAC meeting. ...
Posted by Michael Wonder on 09 May 2024
Government adds two new heart disease treatments on the PBS
9 May 2024 - Australians with different types of cardiomyopathies now have access to new treatments under the Pharmaceutical Benefits Scheme. ...
Posted by Michael Wonder on 05 May 2024
Vyndamax (tafamidis) PBS listed for adult patients with wild type or hereditary transthyretin amyloid cardiomyopathy with New York Heart Association class I-II heart failure
4 May 2024 - The availability of Vyndamax on the PBS provides subsidised access to a once daily oral single ...
Posted by Michael Wonder on 03 May 2024
Agenda for the May 2024 PBAC meeting
3 May 2024 - The agenda for next week's PBAC meeting is now available. Robyn Ward's first meeting as the ...
Posted by Michael Wonder on 30 Apr 2024
Schedule of Pharmaceutical Benefits - 1 May 2024
1 May 2024 - The May 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 29 Apr 2024
Life prolonging breast cancer drug recommended for PBS subsidy, but it is not time to celebrate
26 April 2024 - Breast Cancer Network Australia (BCNA) today welcomed a decision by the PBAC to recommend the life ...
Posted by Michael Wonder on 27 Apr 2024
New hope for Aussies battling early stage breast cancer
28 April 2024 - For the first time in 15 years women with an invasive form of early breast cancer ...
Posted by Michael Wonder on 26 Apr 2024
Recommendations made by the PBAC (March 2024)
26 April 2024 - Recommendations made by the PBAC in March 2024 relating to the listing of medicines on the PBS ...